Learning Objectives:

1. To understand the application of biotherapeutic technology infrastructure on COVID-19 pandemic preparedness

2. To dissect the pathobiology of SARS-CoV-2 through the lens of therapeutic tractability

3. To ascertain from the actions in biopharma, academic and public R&D in the present crisis what new learnings might accelerate therapeutic innovation going forward

Session date: 
Wednesday, April 14, 2021 - 12:00pm to 1:30pm
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation

Please login or create an account to proceed.
Speaker Name: 
Jay Bradner, MD